Literature DB >> 34344868

SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.

Yuanmei Zhu1, Danwei Yu1, Yue Hu1, Tong Wu1, Huihui Chong1, Yuxian He2.   

Abstract

Entities:  

Year:  2021        PMID： 34344868     DOI： 10.1038/s41392-021-00698-x

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  1 in total

1.  Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.

Authors:  Yuanmei Zhu; Danwei Yu; Hongxia Yan; Huihui Chong; Yuxian He
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103
  1 in total
  6 in total

Review 1.  Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.

Authors:  Eunhye Yoon; Dahyun Kim; Hyeeun Jeon; Yejin Kwon; Yejin Jang; Sulhee Kim; Kwang Yeon Hwang
Journal:  Comput Struct Biotechnol J       Date:  2022-06-23       Impact factor: 6.155

2.  Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2.

Authors:  Indrani Das Jana; Prabuddha Bhttacharya; Karthick Mayilsamy; Saptarshi Banerjee; Gourab Bhattacharje; Sayan Das; Seemanti Aditya; Anandita Ghosh; Andrew R McGill; Syamanthak Srikrishnan; Amit Kumar Das; Amit Basak; Shyam S Mohapatra; Bala Chandran; Devesh Bhimsaria; Subhra Mohapatra; Arunava Roy; Arindam Mondal
Journal:  bioRxiv       Date:  2022-03-21

3.  SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron.

Authors:  Yuanmei Zhu; Xiaojing Dong; Nian Liu; Tong Wu; Huihui Chong; Xiaobo Lei; Lili Ren; Jianwei Wang; Yuxian He
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

Review 4.  Lipid and Lipidation in Membrane Fusion.

Authors:  Avijit Sardar; Nikesh Dewangan; Bishvanwesha Panda; Debosmita Bhowmick; Pradip K Tarafdar
Journal:  J Membr Biol       Date:  2022-09-14       Impact factor: 2.426

Review 5.  Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids.

Authors:  Manuel Torres; Sebastià Parets; Javier Fernández-Díaz; Roberto Beteta-Göbel; Raquel Rodríguez-Lorca; Ramón Román; Victoria Lladó; Catalina A Rosselló; Paula Fernández-García; Pablo V Escribá
Journal:  Membranes (Basel)       Date:  2021-11-24

6.  Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.

Authors:  Danwei Yu; Yuanmei Zhu; Hongxia Yan; Tong Wu; Huihui Chong; Yuxian He
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.